UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000005900
Receipt number R000006931
Scientific Title Phase II study of combination chemotherapy with TS-1/irinotecan and bevacizumab as second-line therapy in patient with K-RAS mutation-type metastatic colorectal cancer
Date of disclosure of the study information 2011/07/01
Last modified on 2014/01/09 14:00:46

No. Disposal Last modified on Item of update
1 Insert 2011/07/01 14:03:09
2 Update 2013/08/01 11:54:34 Tel1
Email1
3 Update 2014/01/09 14:00:46 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
TEL